Compounds > celecoxib

celecoxib and montelukast

celecoxib has been researched along with montelukast in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ekins, S; Williams, AJ; Xu, JJ1
Dalvie, D; Loi, CM; Smith, DA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hamatsu, Y; Kataoka, M; Masaoka, Y; Sakuma, S; Yamashita, S; Yano, K1
Abdelhady, SA; Abdelmawgoud, EM; Al-Shafie, TA; Ali, MA; El-Mas, MM; Yacout, DM1

Reviews

1 review(s) available for celecoxib and montelukast

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for celecoxib and montelukast

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt B

    Topics: Absorption; Acetates; Administration, Oral; Animals; Area Under Curve; Caco-2 Cells; Celecoxib; Chemistry, Pharmaceutical; Cyclopropanes; Humans; Indoles; Intestinal Absorption; Male; Permeability; Phenylcarbamates; Pyrazoles; Quinolines; Rats; Rats, Wistar; Solubility; Sulfides; Sulfonamides; Technology, Pharmaceutical; Tosyl Compounds; Water

2013
Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2021, Volume: 70, Issue:9

    Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclopropanes; Diclofenac; Formaldehyde; Inflammation; Male; Nitric Oxide Synthase Type II; Quinolines; Rats; Rats, Wistar; Risk; Signal Transduction; Stomach; Sulfides

2021